Skip to main content
. 2023 Jul 4;60(10):1421–1437. doi: 10.1007/s00592-023-02137-5

Table 1.

Maternal outcomes in overweight or obese women treated with metformin during pregnancy

Overweight women Obese women
Total GWG No significant difference Reduced
GDM rate No significant difference No significant difference
Gestational hypertension/Preeclampsia rate No sufficient data Reduced
Caesarian section Reduced No significant difference
Preterm delivery (< 37 weeks) No sufficient data No significant difference

GWG, Gestational weight gain; GDM, Gestational diabetes